In collaboration with American colleagues, Hajime Hirase will study a novel biological site of attack in the brain – a potential target for schizophrenia drugs. The idea is to take a new approach by manipulating so-called astrocytes; the star-shaped supporting cells that play an important role in converting energy within the central nervous system.

The theory is that using astrocytes as a site of attack will help design drugs that will work better and produce fewer side effects than the medication prescribed by medical professionals to treat schizophrenia today.